Related Experiment Video
Updated: Feb 21, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Risperidone in the Emergency Setting is Associated with More Hypotension in Elderly Patients
Michael P Wilson1, Kimberly Nordstrom2, Austin Hopper1
1Department of Emergency Medicine Behavioral Emergencies Research (DEMBER), University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Background:
Expert consensus panels have recommended risperidone as first-line treatment for agitation of psychiatric origin. However, there are few if any studies on this medication in the emergency setting.
Objectives:
To assess the hemodynamic effects of risperidone in an emergency department (ED) setting, stratified by age.
Methods:
This is a structured chart review of all patients who received oral risperidone over a 6-year period in an ED setting, excluding patients who received this medication as a prescription refill. Vital signs were analyzed for this subset prior to and after medication administration, and changes in vital signs were stratified by age.
Results:
The median dose of risperidone was less in patients aged > 65 years. However, the median drop in systolic blood pressure was larger in this age group compared with younger patients.
Conclusions:
Clinicians tend to be more cautious with dosing of risperidone to geriatric patients in the ED. Despite this, decreases in systolic blood pressure are larger and more frequent in this age group. When possible, clinicians should consider or attempt nonpharmacologic methods of agitation treatment prior to administering medications such as risperidone to elderly patients.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
